Narmada Multispeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 255.33%
- Profit Growth 1336.16%
- Ebitda 1389.68%
- Net Worth 1184.20%
- Total Assets 1689.64%
About Narmada Multispeciality Hospital
Narmada Multispeciality Hospital Private Limited (NMHPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 March 2020 (Four years and 11 months 24 days old ). Its registered office is in Jalgaon, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Shinde, Mayuri Joshi, and Sandip Joshi serve as directors at the Company.
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100MH2020PTC338423
- Company No.
338423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Narmada Multispeciality Hospital?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Shinde  | Director | 02-Mar-2020 | Current |
| Mayuri Joshi | Director | 02-Mar-2020 | Current |
| Sandip Joshi | Director | 02-Mar-2020 | Current |
Financial Performance of Narmada Multispeciality Hospital.
Narmada Multispeciality Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 255.33% increase. The company also saw a substantial improvement in profitability, with a 1336.16% increase in profit. The company's net worth Soared by an impressive increase of 1184.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Narmada Multispeciality Hospital?
Unlock access to Narmada Multispeciality Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Narmada Multispeciality Hospital?
Unlock and access historical data on people associated with Narmada Multispeciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narmada Multispeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narmada Multispeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.